Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 29

1.

Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells.

Nestle FO, Alijagic S, Gilliet M, Sun Y, Grabbe S, Dummer R, Burg G, Schadendorf D.

Nat Med. 1998 Mar;4(3):328-32.

PMID:
9500607
2.

Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma.

Rosenberg SA, Yang JC, Schwartzentruber DJ, Hwu P, Marincola FM, Topalian SL, Restifo NP, Dudley ME, Schwarz SL, Spiess PJ, Wunderlich JR, Parkhurst MR, Kawakami Y, Seipp CA, Einhorn JH, White DE.

Nat Med. 1998 Mar;4(3):321-7.

3.

Human tumor antigens recognized by T-cells.

Kawakami Y, Rosenberg SA.

Immunol Res. 1997;16(4):313-39. Review.

PMID:
9439758
4.

Cytotoxic T-lymphocyte responses against mutated p21 ras peptides: an analysis of specific T-cell-receptor gene usage.

Juretic A, Jürgens-Göbel J, Schaefer C, Noppen C, Willimann TE, Kocher T, Zuber M, Harder F, Heberer M, Spagnoli GC.

Int J Cancer. 1996 Nov 15;68(4):471-8.

5.

Detection of K-ras mutation in sputum by mutant-allele-specific amplification (MASA).

Takeda S, Ichii S, Nakamura Y.

Hum Mutat. 1993;2(2):112-7.

PMID:
8318987
6.

Lysis of ras oncogene-transformed cells by specific cytotoxic T lymphocytes elicited by primary in vitro immunization with mutated ras peptide.

Peace DJ, Smith JW, Chen W, You SG, Cosand WL, Blake J, Cheever MA.

J Exp Med. 1994 Feb 1;179(2):473-9.

7.

Precise prediction of major histocompatibility complex class II-peptide interaction based on peptide side chain scanning.

Hammer J, Bono E, Gallazzi F, Belunis C, Nagy Z, Sinigaglia F.

J Exp Med. 1994 Dec 1;180(6):2353-8.

8.

K-ras and p53 alterations in genomic DNA and transcripts of human pancreatic adenocarcinoma cell lines.

Suwa H, Yoshimura T, Yamaguchi N, Kanehira K, Manabe T, Imamura M, Hiai H, Fukumoto M.

Jpn J Cancer Res. 1994 Oct;85(10):1005-14.

PMID:
7961102
9.

A K-ras 13Gly-->Asp mutation is recognized by HLA-DQ7 restricted T cells in a patient with colorectal cancer. Modifying effect of DQ7 on established cancers harbouring this mutation?

Fossum B, Breivik J, Meling GI, Gedde-Dahl T 3rd, Hansen T, Knutsen I, Rognum TO, Thorsby E, Gaudernack G.

Int J Cancer. 1994 Aug 15;58(4):506-11.

PMID:
7914513
10.

p21-ras-peptide-specific T-cell responses in a patient with colorectal cancer. CD4+ and CD8+ T cells recognize a peptide corresponding to a common mutation (13Gly-->Asp).

Fossum B, Gedde-Dahl T 3rd, Breivik J, Eriksen JA, Spurkland A, Thorsby E, Gaudernack G.

Int J Cancer. 1994 Jan 2;56(1):40-5.

PMID:
7903287
11.

Chemistry of peptides associated with MHC class I and class II molecules.

Rammensee HG.

Curr Opin Immunol. 1995 Feb;7(1):85-96. Review.

PMID:
7772286
13.

Overlapping epitopes encompassing a point mutation (12 Gly-->Arg) in p21 ras can be recognized by HLA-DR, -DP and -DQ restricted T cells.

Fossum B, Gedde-Dahl T 3rd, Hansen T, Eriksen JA, Thorsby E, Gaudernack G.

Eur J Immunol. 1993 Oct;23(10):2687-91.

PMID:
7691613
14.

CD4+ T-cell immunity to mutated ras protein in pancreatic and colon cancer patients.

Qin H, Chen W, Takahashi M, Disis ML, Byrd DR, McCahill L, Bertram KA, Fenton RG, Peace DJ, Cheever MA.

Cancer Res. 1995 Jul 15;55(14):2984-7.

15.

Immunity to oncogenic proteins.

Cheever MA, Disis ML, Bernhard H, Gralow JR, Hand SL, Huseby ES, Qin HL, Takahashi M, Chen W.

Immunol Rev. 1995 Jun;145:33-59. Review. No abstract available.

PMID:
7590829
16.

Four human carcinoma cell lines with novel mutations in position 12 of c-K-ras oncogene.

Valenzuela DM, Groffen J.

Nucleic Acids Res. 1986 Jan 24;14(2):843-52.

17.

Prevalence of ras gene mutations in human colorectal cancers.

Bos JL, Fearon ER, Hamilton SR, Verlaan-de Vries M, van Boom JH, van der Eb AJ, Vogelstein B.

Nature. 1987 May 28-Jun 3;327(6120):293-7.

PMID:
3587348
18.

Genetic alterations during colorectal-tumor development.

Vogelstein B, Fearon ER, Hamilton SR, Kern SE, Preisinger AC, Leppert M, Nakamura Y, White R, Smits AM, Bos JL.

N Engl J Med. 1988 Sep 1;319(9):525-32.

PMID:
2841597
19.

Many gene changes found in cancer.

Marx J.

Science. 1989 Dec 15;246(4936):1386-8. No abstract available.

PMID:
2595361
20.

ras oncogenes in human cancer: a review.

Bos JL.

Cancer Res. 1989 Sep 1;49(17):4682-9. Review. Erratum in: Cancer Res 1990 Feb 15;50(4):1352.

Supplemental Content

Support Center